Sponsored
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
Posted
Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
51-foot-tall statue of Lord Ram unveiled in Canada's Mississauga, mayor says 'spectacular landmark for Hindu community'
A towering 51-foot statue of Lord Ram, inspired by the Ayodhya temple, has been unveiled in...
UAE participates in 3rd UN Conference on Landlocked Developing Countries in Turkmenistan
The Third UN Conference on Landlocked Developing Countries (LLDC3) opened on 5 August 2025 in...
Communication Minister urges media to embrace new online registration process
KATHMANDU: Minister for Communication and Information Technology, Prithvi Subba Gurung, has said...
Hrithik and NTR's Janaabe Aali look teases dance face-off
'War 2' makers unveiled the first look of the high-energy song "Janaabe Aali", featuring Hrithik...